Houlihan Lokey Advises Webster Equity Partners
Houlihan Lokey is pleased to announce that Webster Equity Partners (Webster), a private equity firm focused on investing in and developing purpose-driven, patient-centric healthcare organizations, has made a strategic investment in Penn Quarter Partners (PQP), a highly specialized consulting platform for life sciences companies navigating complex regulatory, policy, and market challenges. The terms of the transaction were not disclosed.
Founded in 2011, PQP is a Washington, D.C.-based company that has guided companies at the forefront of medical advancements with strategic planning, research and analytics, campaign and issues management, and integrated communications. The firm’s success is built on deep, long-standing client relationships and a seasoned team with expertise across the diagnostic, device, and biopharmaceutical sectors.
Founded in 2003, Webster is a private equity firm that focuses on high-impact growth strategies that seek to deliver optimal outcomes for its investors, portfolio companies, and the communities that they serve. Webster’s investment will help PQP deepen its capabilities, expand its reach, and continue building its position as a market leader for companies at the cutting edge of science and innovation.
Houlihan Lokey served as the exclusive financial advisor to Webster. This deal highlights Houlihan Lokey’s leading experience in the pharma commercialization space and represents the firm’s 31st transaction in this sector since 2019.